$SGEN is guided higher after much better than expected clinical trial data along with partner $GMAB. Strong checks for $TDOC and looking for re-entry near $175. Cautious view on regional banks $KRE. Nice technical setup for breakout in $HELE which Jay covered in Weekend Research previously. $PINS saw over $2.5M call premium accumulate in August 21 calls yesterday.